(2α,3α,5α,17β)-2,3-Epoxy-17-methylandrostan-17-ol is an intermediate in the synthesis of 17α-Methyl-5α-androstane-2β,3α,17β)-triol (M327240), which is a derivative of Madol (M108000, which is an anabolic steroid recently identified to be misused as a doping agent. The potency of Madol (DMT) to transactivate androgen receptor (AR) dependent reporter gene expression was two times lower as compared to dihydrotestosterone (DHT).